Theresa Tribble
Vorstandsvorsitzender bei Droplet Biosciences, Inc.
Profil
Theresa Tribble is currently the President, Chief Executive Officer & Director at Droplet Biosciences, Inc. and also serves as a Director at Kytopen Corp.
She previously worked as a Senior Director-Clinical Market Development at SynapDx Corp.
and as a Principal at Putnam Associates LLC.
Ms. Tribble completed her undergraduate degree at Wellesley College and earned an MBA from Harvard Business School.
Aktive Positionen von Theresa Tribble
Unternehmen | Position | Beginn |
---|---|---|
Droplet Biosciences, Inc.
Droplet Biosciences, Inc. BiotechnologyHealth Technology Droplet Biosciences, Inc. specializes in non-invasive liquid biopsy techniques that can unlock lymphatic insights to aid in post-operative treatment decisions. The company is based in Melrose, MA. The lymphatic system is the most common means of metastasis in over 90% of cancer cases. The CEO of the company is Theresa Tribble. | Vorstandsvorsitzender | 01.05.2021 |
Kytopen Corp.
Kytopen Corp. Miscellaneous Commercial ServicesCommercial Services Kytopen Corp. engages in the provision of technology solutions. It develops genetically engineered cells that modifies microorganisms. The company was founded by Paulo A. Gracia and Cullen R. Buie in 2017 and is headquartered in Cambridge, MA. | Direktor/Vorstandsmitglied | - |
Ehemalige bekannte Positionen von Theresa Tribble
Unternehmen | Position | Ende |
---|---|---|
Putnam Associates LLC
Putnam Associates LLC Miscellaneous Commercial ServicesCommercial Services Putnam Associates LLC engages in the provision of strategic consulting serving biopharmaceutical, diagnostics, and medical device clients. It specializes in corporate strategy, portfolio licensing and development strategy, new product, established products and franchise strategy, pricing, reimbursement and market access, and other related strategic projects. The company was founded by Kevin J. Gorman in 1988 and is headquartered in Boston, MA. | Corporate Officer/Principal | - |
SynapDx Corp.
SynapDx Corp. Miscellaneous Commercial ServicesCommercial Services SynapDx Corp. operates as a laboratory services company which develops a blood-based test for the early detection of autism spectrum disorder. It provides laboratory testing services to physicians who evaluate children for developmental disorders with the initial goal of enabling earlier detection of autism. The company was founded by Stanley N. Lapidus, Jeffrey R. Luber, Graham Gardner and Patrick A. Anquetil in 2010 and is headquartered in Lexington, MA. | Corporate Officer/Principal | - |
Ausbildung von Theresa Tribble
Wellesley College | Undergraduate Degree |
Harvard Business School | Masters Business Admin |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
Private Unternehmen | 4 |
---|---|
SynapDx Corp.
SynapDx Corp. Miscellaneous Commercial ServicesCommercial Services SynapDx Corp. operates as a laboratory services company which develops a blood-based test for the early detection of autism spectrum disorder. It provides laboratory testing services to physicians who evaluate children for developmental disorders with the initial goal of enabling earlier detection of autism. The company was founded by Stanley N. Lapidus, Jeffrey R. Luber, Graham Gardner and Patrick A. Anquetil in 2010 and is headquartered in Lexington, MA. | Commercial Services |
Putnam Associates LLC
Putnam Associates LLC Miscellaneous Commercial ServicesCommercial Services Putnam Associates LLC engages in the provision of strategic consulting serving biopharmaceutical, diagnostics, and medical device clients. It specializes in corporate strategy, portfolio licensing and development strategy, new product, established products and franchise strategy, pricing, reimbursement and market access, and other related strategic projects. The company was founded by Kevin J. Gorman in 1988 and is headquartered in Boston, MA. | Commercial Services |
Kytopen Corp.
Kytopen Corp. Miscellaneous Commercial ServicesCommercial Services Kytopen Corp. engages in the provision of technology solutions. It develops genetically engineered cells that modifies microorganisms. The company was founded by Paulo A. Gracia and Cullen R. Buie in 2017 and is headquartered in Cambridge, MA. | Commercial Services |
Droplet Biosciences, Inc.
Droplet Biosciences, Inc. BiotechnologyHealth Technology Droplet Biosciences, Inc. specializes in non-invasive liquid biopsy techniques that can unlock lymphatic insights to aid in post-operative treatment decisions. The company is based in Melrose, MA. The lymphatic system is the most common means of metastasis in over 90% of cancer cases. The CEO of the company is Theresa Tribble. | Health Technology |